Initial Experience with Watchman® Left Atrial Appendage Occluder Device Implantation—Lessons from Transoesophageal Echocardiographic Guidance

2010 ◽  
Vol 19 ◽  
pp. S186
Author(s):  
J. Humphries ◽  
K. Phillips
Heart Rhythm ◽  
2014 ◽  
Vol 11 (11) ◽  
pp. 1877-1883 ◽  
Author(s):  
Anand M. Pillai ◽  
Arun Kanmanthareddy ◽  
Matthew Earnest ◽  
Madhu Reddy ◽  
Ryan Ferrell ◽  
...  

2021 ◽  
Vol 5 (3) ◽  
Author(s):  
Stefano Albani ◽  
Nicola Berlier ◽  
Francesco Pisano ◽  
Paolo Scacciatella

Abstract Background Late-onset complications of left atrial appendage occlusion (LAAO) device procedure are anecdotal and there are no such complications reported in literature using Cardia Ultraseal (Cardia, Inc., Eagan, MN, USA). Case summary We report the case of a 74-year-old Caucasian man affected by paroxysmal atrial fibrillation with significant bleeding risk (familiar thrombocytopenia, macroscopic haematuria episodes during therapy with direct oral anticoagulants, HAS-BLED risk score: 4) and ischaemic risk as well (CHADSVASC score: 3). The patient was treated with LAAO device implantation for high bleeding risk. Subsequently, after 26 days from LAAO procedure, he was admitted to the emergency department for haematic cardiac tamponade. The patient was successfully treated with subxyphoidal pericardiocentesis in the acute phase, unfortunately cardiac arrest occurred during the transfer to the referral hospital for urgent cardiac surgery. Permanent neurological damage was reported and the patient died on day 28. Discussion LAAO late-onset complications are very rare and the case presented is the first case described of late-onset pericardial effusion and tamponade secondary to the Cardia Ultraseal LAAO device implantation. We present a revision of the literature regarding the occurrence of similar adverse events and discuss the hypothetical mechanism of this major complication.


2021 ◽  
Vol 3 (3) ◽  
pp. 508-511
Author(s):  
Omar Kousa ◽  
Toufik Mahfood-Haddad ◽  
Shantanu M. Patil ◽  
Himanshu Agarwal ◽  
Hussam Abuissa

2018 ◽  
Vol 71 (9) ◽  
pp. 755-756 ◽  
Author(s):  
Ignacio Cruz-González ◽  
Xavier Freixa ◽  
José Antonio Fernández-Díaz ◽  
José Carlos Moreno-Samos ◽  
Victoria Martín-Yuste ◽  
...  

Author(s):  
Domenico G. Della Rocca ◽  
Rodney P. Horton ◽  
Nicola Tarantino ◽  
Christoffel Johannes Van Niekerk ◽  
Chintan Trivedi ◽  
...  

Background: Interventional therapies aiming at excluding the left atrial appendage (LAA) from systemic circulation have been established as a valid alternative to oral anticoagulation in patients at high thromboembolic risk. However, their efficacy on stroke prophylaxis may be compromised owing to incomplete LAA closure. Additionally, the need for an alternative thromboembolic prevention may remain unmet in patients with contraindications to oral anticoagulation whose appendage anatomy is unsuitable for some conventional devices commercially available. We aimed at evaluating the feasibility of LAA closure with the novel Gore Cardioform Septal Occluder in patients with incomplete appendage ligation or anatomic features which do not meet the manufacturer’s requirements for Watchman deployment. Methods: Twenty-one consecutive patients (mean age: 72±6 years; 85.7% males; CHA 2 DS 2 -VASc: 4.5±1.4; HAS-BLED: 3.6±1.0) were included. Transesophageal echocardiography was performed within 2 months to assess for residual LAA patency. Results: Fourteen patients had incomplete LAA closure following surgical (n=6) or Lariat ligation (n=8). In 7 patients with an appendage anatomy unsuitable for Watchman deployment, the mean maximal landing zone size and LAA depth were 14.4±1.3 and 18.6±2.8 mm. Successful Cardioform Septal Occluder deployment was achieved in all patients. No peri-procedural complications were documented. Procedure and fluoroscopy times were 46±13 and 14±5 minutes. Follow-up transesophageal echocardiography after 58±9 days revealed complete LAA closure in all patients. Conclusions: Transcatheter LAA closure via a Cardioform Septal Occluder device might be a valid alternative in patients with residual leaks following failed appendage ligation or whose LAA anatomy does not meet the minimal anatomic criteria to accommodate a Watchman device. Graphic Abstract: A graphic abstract is available for this article.


Global Heart ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e45
Author(s):  
A. Carrizo ◽  
M. Natarajan ◽  
J. Velianou ◽  
S. Divakaramenon ◽  
C.A. Morillo

2020 ◽  
Vol 8 (10) ◽  
pp. 2021-2024
Author(s):  
Simone Zanchi ◽  
Lorenzo Bianchini ◽  
Stefano Bordignon ◽  
Fabrizio Bologna ◽  
Shota Tohoku ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document